Brief: Virios Therapeutics Says All Employees Have Agreed To 10% Salary Compensation Reduction In Exchange For Future Vesting Stock Options

Dogwood Therapeutics

28/02/2024 14:19

Feb 28 (Reuters) - Virios Therapeutics Inc  VIRI.O :
    * VIRIOS THERAPEUTICS INC: ALL OF VIRIOS' EMPLOYEES HAVE
AGREED TO
10% SALARY COMPENSATION REDUCTION IN EXCHANGE FOR FUTURE VESTING
STOCK OPTIONS
    * VIRIOS THERAPEUTICS INC - DIRECTORS HAVE ALSO AGREED TO A
10%
REDUCTION IN CASH DIRECTOR FEES
    * VIRIOS THERAPEUTICS INC - REQUESTING SHAREHOLDER APPROVAL
TO
EXECUTE A REVERSE STOCK SPLIT SOME TIME OVER COURSE OF NEXT 12
MONTHS
    * VIRIOS THERAPEUTICS INC - EXPECT TO RECEIVE TOP LINE
RESULTS
FROM BATEMAN HORNE CENTER INDEPENDENT INVESTIGATOR SUPPORTED
STUDY IN SECOND HALF OF 2024
    * VIRIOS THERAPEUTICS INC -  APPROVAL OF REVERSE STOCK SPLIT
PROPOSAL DOES NOT COMMIT COMPANY TO EXECUTION OF A REVERSE STOCK
SPLIT
    * VIRIOS THERAPEUTICS INC - HAVE CLARITY FROM FDA ON
DEVELOPMENT
REQUIREMENTS FOR ADVANCING IMC-2 INTO PHASE 2 DEVELOPMENT AS
TREATMENT FOR LC SYMPTOMS

Source text for Eikon:  ID:nGNX79GvGZ 
Further company coverage:  VIRI.O 

 ((Reuters.Briefs@thomsonreuters.com;))